uso de inhibidores de la bomba de

107 Howell M, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D. Iatrogenic GastricAcid Suppression and the Risk of Nosocomial Clostridium difficile Infection. Arch Intern Med.2010;170(9):784-790.108 FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated withstomach acid drugs known as proton pump inhibitors (PPIs). Disponible en:http://www.fda.gov/Drugs/DrugSafety/ucm290510.htm (consultado el 5-3-2011).109 Force RW, Meeker AD, Cady PS, Culbertson VL, Force WS, Kelley CM. Increased vitamin B12requirement associated with chronic acid suppression therapy. Ann Pharmacother. 2003; 37: 490 – 3.110 Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitoruse and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004;57:422-428.111 Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-Pump Inhibitor Therapy Induces Acid-RelatedSymptoms in Healthy Volunteers After Withdrawal of Therapy Gastroenterology. 2009; 137(1):80-87.112 Epstein M , McGrath S , Law F . Proton pump inhibitors and hypomagnesemic hypoparathyroidism. NEngl J Med. 2006; 355: 1834 – 6.113 Subbiah V, Tayek JA. Tetany secondary to the use of a proton-pump inhibitor. Ann Intern Med. 2002;137(3):219.114 FDA Drug Safety Communication: Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication -Low Magnesium Levels Can Be Associated With Long-Term Use [Posted 03/02/2011]. Disponible en:http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245275.htm (consultado el 5-3-2011).115 Nota informativa de la AEMPS. Ref: 2011/27, de 23 de diciembre de 2011. Disponible en:http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2011/docs/NI-MUH_27-2011.pdf (consultada 5-3-2012).116Callejas Díaz A, et al. Omeprazol e hipomagnesemia. Rev Clin Esp. 2011.doi:10.1016/j.rce.2011.01.013117 Hippisley-Cox J, Coupland C. Risk of adverse gastrointestinal outcomes in patients taking cyclooxygenase-2inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nestedcase-control analysis. BMJ. 2005;331:1310-1316. Disponible en:http://www.bmj.com/content/331/7528/1310.full?etoc%2520 (consultado 8-3-2011)118 Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley-Cox J, et al. EU-ADRConsortium Combining electronic healthcare databases in Europe to allow for large-scale drug safetymonitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20(1):1-11. Disponible en:http://onlinelibrary.wiley.com/doi/10.1002/pds.2053/full (consultada 8-3-2011).119 Hunt RH, Lanas A, Stichtenoth DO, Scarpignato C. Myths and facts in the use of anti-inflammatorydrugs. Ann Med. 2009;41(6):423-37.120 Sultan A, McQuay HJ, Moore RA, Derry S. Single dose oral flurbiprofen for acute postoperative painin adults. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007358. DOI:10.1002/14651858.CD007358.pub2.121 Hall PE, Derry S, Moore RA, McQuay HJ. Single dose oral lornoxicam for acute postoperative pain inadults. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007441. DOI:10.1002/14651858.CD007441.pub2.122 Lanas A, McCarthy D, Voelker M, Brueckner A, Senn S, Baron J. Short-Term Acetylsalicylic Acid(Aspirin) Use for Pain, Fever, or Colds – Gastrointestinal Adverse Effects: A Meta-Analysis ofRandomized Clinical Trials. Drugs. 2011; 11 (3): 277-288.101